Table 1 Migraine characteristics at inclusion in the 52 patients
Variable | |
|---|---|
Overuse of symptomatic medication | 43/52 (82.7%) |
- Analgesics | 31/52 (59.6%) |
- Combined medications | 12/52 (23.1%) |
Previous use of neuromodulators | 52/52 (100%) |
- Topiramate | 48/52 (92.3%) |
- Other | 26/52 (50%) |
Previous use of beta-blockers | 46/52 (88.5%) |
Previous use of Calcium channel antagonists | 33/52 (63.5%) |
Previous use of antidepressants | 30/52 (57.7%) |
Previous use of anaesthetic blockades | 11/52 (21.1%) |
Monthly headache days | 23.4 ± 6.3 (15–30)* |
Monthly migraine days | 13.9 ± 7.3 (8–30)* |
Monthly symptomatic medication intake days | 17.7 ± 9.2 (3–30)* |
Monthly triptan intake days | 5.1 ± 6.9 (0–25)* |
Monthly visits to emergency department | 0.25 ± 0.9 (0–6)* |